{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T12:46:46Z","timestamp":1774442806050,"version":"3.50.1"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2013,6,28]],"date-time":"2013-06-28T00:00:00Z","timestamp":1372377600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Gastric Cancer"],"published-print":{"date-parts":[[2014,4]]},"DOI":"10.1007\/s10120-013-0277-3","type":"journal-article","created":{"date-parts":[[2013,6,27]],"date-time":"2013-06-27T12:17:43Z","timestamp":1372335463000},"page":"247-254","source":"Crossref","is-referenced-by-count":20,"title":["Aberrant expression of SOX9 is associated with gastrokine 1 inactivation in gastric cancers"],"prefix":"10.1007","volume":"17","author":[{"given":"Yoo Jin","family":"Choi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jae Hwi","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jung Hwan","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Won Suk","family":"Choi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suk Woo","family":"Nam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jung Young","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Won Sang","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,6,28]]},"reference":[{"key":"277_CR1","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3322\/canjclin.55.1.10","volume":"55","author":"A Jemal","year":"2005","unstructured":"Jemal A, Murray T, Ward E, Samuels A, Tiwari RC, Ghafoor A, et al. Cancer statistics, 2005. CA Cancer J Clin. 2005;55:10\u201330.","journal-title":"CA Cancer J Clin"},{"key":"277_CR2","doi-asserted-by":"crossref","first-page":"25","DOI":"10.4143\/crt.2012.44.1.25","volume":"1","author":"KW Jung","year":"2012","unstructured":"Jung KW, Park SH, Won YJ, Kong HJ, Lee JY, Seo HG, et al. Prediction of cancer incidence and mortality in Korea, 2012. Cancer Res Treat. 2012;1:25\u201331.","journal-title":"Cancer Res Treat"},{"key":"277_CR3","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1038\/nrc1141","volume":"3","author":"Y Yuasa","year":"2003","unstructured":"Yuasa Y. Control of gut differentiation and intestinal-type gastric carcinogenesis. Nat Rev Cancer. 2003;3:592\u2013600.","journal-title":"Nat Rev Cancer"},{"key":"277_CR4","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.3892\/or.14.1.291","volume":"14","author":"M Katoh","year":"2005","unstructured":"Katoh M. Wnt\/PCP signaling pathway and human cancer. Oncol Rep. 2005;14:1583\u20138.","journal-title":"Oncol Rep"},{"key":"277_CR5","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.gde.2006.12.007","volume":"17","author":"P Polakis","year":"2007","unstructured":"Polakis P. The many ways of Wnt in cancer. Curr Opin Genet Dev. 2007;17:45\u201351.","journal-title":"Curr Opin Genet Dev"},{"key":"277_CR6","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1002\/path.2838","volume":"223","author":"JH Yoon","year":"2011","unstructured":"Yoon JH, Song JH, Zhang C, Jin M, Kang YH, Nam SW, et al. Inactivation of the gastrokine 1 gene in gastric adenomas and carcinomas. J Pathol. 2011;223:618\u201325.","journal-title":"J Pathol"},{"key":"277_CR7","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1007\/s00432-011-1051-8","volume":"137","author":"JH Yoon","year":"2011","unstructured":"Yoon JH, Kang YH, Choi YJ, Park IS, Nam SW, Lee JY, et al. Gastrokine 1 functions as a tumor suppressor by inhibition of epithelial\u2013mesenchymal transition in gastric cancers. J Cancer Res Clin Oncol. 2011;137:1697\u2013704.","journal-title":"J Cancer Res Clin Oncol"},{"key":"277_CR8","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1002\/path.2335","volume":"215","author":"R Hersmus","year":"2008","unstructured":"Hersmus R, Kalfa N, de Leeuw B, Stoop H, Oosterhuis JW, de Krijger R, et al. FOXL2 and SOX9 as parameters of female and male gonadal differentiation in patients with various forms of disorders of sex development (DSD). J Pathol. 2008;215:31\u20138.","journal-title":"J Pathol"},{"key":"277_CR9","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1158\/0008-5472.CAN-04-1484","volume":"65","author":"P Jay","year":"2005","unstructured":"Jay P, Berta P, Blache P. Expression of the carcinoembryonic antigen gene is inhibited by SOX9 in human colon carcinoma cells. Cancer Res. 2005;65:2193\u20138.","journal-title":"Cancer Res"},{"key":"277_CR10","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1002\/dvdy.22046","volume":"239","author":"JD Kormish","year":"2010","unstructured":"Kormish JD, Sinner D, Zorn AM. Interactions between SOX factors and Wnt\/beta-catenin signaling in development and disease. Dev Dyn. 2010;239:56\u201368.","journal-title":"Dev Dyn"},{"key":"277_CR11","doi-asserted-by":"crossref","first-page":"3795","DOI":"10.1242\/dev.01259","volume":"131","author":"B Moniot","year":"2004","unstructured":"Moniot B, Biau S, Faure S, Nielsen CM, Berta P, Roberts DJ, et al. SOX9 specifies the pyloric sphincter epithelium through mesenchymal\u2013epithelial signals. Development (Camb). 2004;131:3795\u2013804.","journal-title":"Development (Camb)"},{"key":"277_CR12","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1007\/s00535-011-0443-5","volume":"46","author":"M Sashikawa Kimura","year":"2011","unstructured":"Sashikawa Kimura M, Mutoh H, Sugano K. SOX9 is expressed in normal stomach, intestinal metaplasia, and gastric carcinoma in humans. J Gastroenterol. 2011;46:1292\u20139.","journal-title":"J Gastroenterol"},{"key":"277_CR13","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s00428-012-1201-7","volume":"460","author":"M Sun","year":"2012","unstructured":"Sun M, Uozaki H, Hino R, Kunita A, Shinozaki A, Ushiku T, et al. SOX9 expression and its methylation status in gastric cancer. Virchows Arch. 2012;460:271\u20139.","journal-title":"Virchows Arch"},{"key":"277_CR14","doi-asserted-by":"crossref","first-page":"10646","DOI":"10.1073\/pnas.0504927102","volume":"102","author":"AT Franco","year":"2005","unstructured":"Franco AT, Israel DA, Washington MK, Krishna U, Fox JG, Rogers AB, et al. Activation of beta-catenin by carcinogenic Helicobacter pylori. Proc Natl Acad Sci USA. 2005;102:10646\u201351.","journal-title":"Proc Natl Acad Sci USA"},{"key":"277_CR15","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1038\/18884","volume":"398","author":"O Tetsu","year":"1999","unstructured":"Tetsu O, McCormick F. Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature (Lond). 1999;398:422\u20136.","journal-title":"Nature (Lond)"},{"key":"277_CR16","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1083\/jcb.200311021","volume":"166","author":"P Blache","year":"2004","unstructured":"Blache P, van de Wetering M, Duluc I, Domon C, Berta P, Freund JN, et al. SOX9 is an intestine crypt transcription factor, is regulated by the Wnt pathway, and represses the CDX2 and MUC2 genes. J Cell Biol. 2004;166:37\u201347.","journal-title":"J Cell Biol"},{"key":"277_CR17","doi-asserted-by":"crossref","first-page":"3484","DOI":"10.1007\/s12032-012-0267-z","volume":"29","author":"L Wang","year":"2012","unstructured":"Wang L, He S, Yuan J, Mao X, Cao Y, Zong J, et al. Oncogenic role of SOX9 expression in human malignant glioma. Med Oncol. 2012;29:3484\u201390.","journal-title":"Med Oncol"},{"key":"277_CR18","doi-asserted-by":"crossref","unstructured":"Sun L, Mathews LA, Cabarcas SM, Zhang X, Yang A, Zhang Y, et al. Epigenetic regulation of SOX9 by the NF-\u03baB signaling pathway in pancreatic cancer stem cells. 2013 (in press).","DOI":"10.1002\/stem.1394"},{"key":"277_CR19","doi-asserted-by":"crossref","unstructured":"Yu CC, Tsai LL, Wang ML, Yu CH, Lo WL, Chang YC, et al. miR145 targets the SOX9\/ADAM17 axis to inhibit tumor initiating cells and IL-6-mediated paracrine effects in head and neck cancer. Cancer Res. 2013;73:3425\u201340.","DOI":"10.1158\/0008-5472.CAN-12-3840"},{"key":"277_CR20","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1309\/AJCPW1W8GJBQGCNI","volume":"130","author":"B Lu","year":"2008","unstructured":"Lu B, Fang Y, Xu J, Wang L, Xu F, Xu E, et al. Analysis of SOX9 expression in colorectal cancer. Am J Clin Pathol. 2008;130:897\u2013904.","journal-title":"Am J Clin Pathol"},{"key":"277_CR21","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1158\/0008-5472.CAN-07-5915","volume":"68","author":"H Wang","year":"2008","unstructured":"Wang H, Leav I, Ibaragi S, Wegner M, Hu GF, Lu ML, et al. SOX9 is expressed in human fetal prostate epithelium and enhances prostate cancer invasion. Cancer Res. 2008;68:1625\u201330.","journal-title":"Cancer Res"},{"key":"277_CR22","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1258\/ebm.2010.010086","volume":"236","author":"G Chakravarty","year":"2011","unstructured":"Chakravarty G, Moroz K, Makridakis NM, Lloyd SA, Galvez SE, Canavello PR, et al. Prognostic significance of cytoplasmic SOX9 in invasive ductal carcinoma and metastatic breast cancer. Exp Biol Med. 2011;236:145\u201355.","journal-title":"Exp Biol Med"},{"key":"277_CR23","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1038\/onc.2012.224","volume":"32","author":"S Radulescu","year":"2013","unstructured":"Radulescu S, Ridgway RA, Cordero J, Athineos D, Salgueiro P, Poulsom R, et al. Acute Wnt signalling activation perturbs differentiation within the adult stomach and rapidly leads to tumour formation. Oncogene. 2013;32:2048\u201357.","journal-title":"Oncogene"},{"key":"277_CR24","doi-asserted-by":"crossref","unstructured":"Panza A, Pazienza V, Ripoli M, Benegiamo G, Gentile A, Rosaria M, et al. Interplay between SOX9, \u03b2-catenin, and PPAR\u03b3 activation in colorectal cancer. Biochim Biophys Acta. 2013;1833:1853\u201365.","DOI":"10.1016\/j.bbamcr.2013.04.004"}],"container-title":["Gastric Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10120-013-0277-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10120-013-0277-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10120-013-0277-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T03:05:26Z","timestamp":1715569526000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10120-013-0277-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6,28]]},"references-count":24,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,4]]}},"alternative-id":["277"],"URL":"https:\/\/doi.org\/10.1007\/s10120-013-0277-3","relation":{},"ISSN":["1436-3291","1436-3305"],"issn-type":[{"value":"1436-3291","type":"print"},{"value":"1436-3305","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,6,28]]}}}